Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.200
-0.020 (-0.62%)
At close: Jan 17, 2025, 4:00 PM
3.237
+0.037 (1.16%)
After-hours: Jan 17, 2025, 6:13 PM EST
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 377 employees as of December 31, 2023. The number of employees increased by 22 or 6.20% compared to the previous year.
Employees
377
Change (1Y)
22
Growth (1Y)
6.20%
Revenue / Employee
$496,979
Profits / Employee
-$167,408
Market Cap
477.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
XERS News
- 10 days ago - Xeris Expects to Exceed Full-Year 2024 Financial Guidance - Business Wire
- 14 days ago - Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 2 months ago - Xeris Biopharma Holdings, Inc. (XERS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Xeris Biopharma Reports Third Quarter 2024 Financial Results - Business Wire
- 2 months ago - Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 - Business Wire
- 3 months ago - Xeris Biopharma Holdings: Promising Pipeline And Strategic Partnerships Make It Attractive - Seeking Alpha
- 3 months ago - Undercovered Dozen: KinderCare Learning, Xeris Biopharma, Generac, Philips + - Seeking Alpha